BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21325284)

  • 1. CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.
    Fiorentino FP; Macaluso M; Miranda F; Montanari M; Russo A; Bagella L; Giordano A
    Mol Cancer Res; 2011 Feb; 9(2):225-33. PubMed ID: 21325284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma.
    Macaluso M; Caracciolo V; Rizzo V; Sun A; Montanari M; Russo G; Bellipanni G; Khalili K; Giordano A
    Cell Cycle; 2012 May; 11(9):1841-50. PubMed ID: 22544282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer.
    Cinti C; Macaluso M; Giordano A
    Oncogene; 2005 Sep; 24(38):5821-6. PubMed ID: 16044156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis.
    Russo G; Claudio PP; Fu Y; Stiegler P; Yu Z; Macaluso M; Giordano A
    Oncogene; 2003 Oct; 22(44):6959-69. PubMed ID: 14534545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
    Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV
    Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells.
    Kang Y; Hong JA; Chen GA; Nguyen DM; Schrump DS
    Oncogene; 2007 Jun; 26(30):4394-403. PubMed ID: 17260018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.
    Claudio PP; Howard CM; Pacilio C; Cinti C; Romano G; Minimo C; Maraldi NM; Minna JD; Gelbert L; Leoncini L; Tosi GM; Hicheli P; Caputi M; Giordano GG; Giordano A
    Cancer Res; 2000 Jan; 60(2):372-82. PubMed ID: 10667590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation.
    Paggi MG; Bonetto F; Severino A; Baldi A; Battista T; Bucci F; Felsani A; Lombardi D; Giordano A
    Oncogene; 2001 May; 20(20):2570-8. PubMed ID: 11420667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of alterations of Rb2/p130 tumor suppressor in all-trans-retinoic acid resistant SK-OV3 ovarian carcinoma cells.
    Fields AL; Soprano DR; Soprano KJ
    J Cell Physiol; 2008 Oct; 217(1):77-85. PubMed ID: 18446820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTCF and BORIS in genome regulation and cancer.
    Marshall AD; Bailey CG; Rasko JE
    Curr Opin Genet Dev; 2014 Feb; 24():8-15. PubMed ID: 24657531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.
    Baldi A; Esposito V; De Luca A; Fu Y; Meoli I; Giordano GG; Caputi M; Baldi F; Giordano A
    Clin Cancer Res; 1997 Oct; 3(10):1691-7. PubMed ID: 9815552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PP2A interaction with Rb2/p130 mediates translocation of Rb2/p130 into the nucleus in all-trans retinoic acid-treated ovarian carcinoma cells.
    Purev E; Soprano DR; Soprano KJ
    J Cell Physiol; 2011 Apr; 226(4):1027-34. PubMed ID: 20857408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
    Eldholm V; Haugen A; Zienolddiny S
    Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The detection of Rb2/p130 and p53 gene mutations by denaturing high-performance liquid chromatography analysis of sputum of lung cancer patients and its clinical implications].
    Wang BC; Li LY; Cheng SJ; Gao YN
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):499-501. PubMed ID: 15312402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.